Medically reviewed by Corinne Savides Happel, MD Hereditary angioedema (HAE) is a genetic disorder that causes episodes of ...

Discover the symptoms, causes and treatments for hereditary angioedema, a rare genetic disorder causing severe swelling that ...

Patients with hereditary angioedema who switched from other drugs to donidalorsen for long-term prophylaxis experienced fewer ...

Intellia has reported results from a phase 2 trial of its gene-editing drug for hereditary angioedema (HAE) that it says build the case for the drug as a phase 3 trial gets underway – but its ...

KalVista's sebetralstat nears FDA approval as a first-in-class oral treatment for hereditary angioedema. Read here for an ...

Significant advances in treatment for chronic spontaneous urticaria (CSU), hereditary angioedema (HAE), and anaphylaxis were presented at the American Academy of Allergy, Asthma and Immunology ...

BHUBANESWAR : Hereditary angioedema is a rare genetic disorder which can affect several members of the family, said experts at a CME organised at SCB Medical College and Hospital at Cuttack.

oral bradykinin B2 receptor antagonists to help address unmet needs of those living with bradykinin-mediated diseases such as hereditary angioedema (HAE) and acquired angioedema due to C1 ...

Takhzyro (lanadelumab-flyo) is a prescription drug that’s used to help prevent attacks of hereditary angioedema (HAE). Takhzyro comes as a subcutaneous injection. Takhzyro is used to help ...

RESEARCH TRIANGLE PARK, N.C., April 21, 2025 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that the company will report its first quarter 2025 financial results on ...

KalVista Pharmaceuticals, Inc. (Nasdaq: KALV) today announced that its wholly-owned subsidiary, KalVista Pharmaceuticals, Ltd., has licensed commercialization rights in Japan to Kaken Pharmaceutical, ...